US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 6.110
  • +0.490+8.72%
Close Jul 11 16:00 ET
  • 6.250
  • +0.140+2.29%
Post 19:56 ET
255.72MMarket Cap-4628P/E (TTM)

Zevra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zevra Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

3.43M

+7.84%
EPS(YoY)

-0.40

-5.26%
Analyst Rating

Strong Buy

Jul 9, 2024

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.447M--
--2024/Q2-- / 4.407M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
Nov 7, 20232023/Q32.895M / 3.379M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.447M--
--2024/Q2-- / 4.407M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
Nov 7, 20232023/Q32.895M / 3.379M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 9 16:38 ET

  • Zevra Therapeutics | 10-K: Annual report

    Apr 1 17:33 ET

  • Zevra Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 17:23 ET

  • Zevra Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg